USA · PI Dr. Okafor · activated
Patients
19
Active
0
Serious AEs
0
Open QA
2
Aged queries
0
Luna users
0
Studies & contracts
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II · study completed · contract executed · 225500 USD
Patients (19)
703-1042 ›
completed
703-1076 ›
completed
703-1086 ›
completed
703-1096 ›
withdrawn
703-1100 ›
completed
703-1119 ›
completed
703-1175 ›
completed
703-1182 ›
completed
703-1197 ›
withdrawn
703-1210 ›
completed
703-1258 ›
completed
703-1279 ›
withdrawn
703-1295 ›
withdrawn
703-1299 ›
completed
703-1335 ›
completed
703-1379 ›
completed
703-1396 ›
screened
703-1403 ›
completed
703-1439 ›
completed
Safety — 61 AEs, 0 serious
No serious adverse events.
QA findings (2 open)
open
major
PROTOCOL VIOLATION: PROTOCOL ENTRY CRITERIA NOT MET (subject 703-1175, 2013-12-31)
open
major
PROTOCOL VIOLATION: PROTOCOL VIOLATION (subject 703-1335, 2014-05-24)
Visits & payments
Nothing scheduled.
☾ Luna participants
No Luna participants here yet.